|
|
Found results for
 patents
1.
|
Pharmaceutical compositions comprising cannabidiol and beta-caryophyllene and methods for their use
| Application Number |
17509718 |
| Grant Number |
11529320 |
| Status |
In Force |
| Filing Date |
2021-10-25 |
| First Publication Date |
2022-02-10 |
| Grant Date |
2022-12-20 |
| Owner |
Phytecs, Inc. (USA)
|
| Inventor |
- Biro, Tamas
- Russo, Ethan B.
|
Abstract
The disclosure describes compositions comprising beta-caryophyllene (BCP) and cannabidiol (CBD). The disclosure also describes compositions which further introduce low levels of THC. The disclosure further describes methods of making and using said compositions, including for the treatment of chronic pain, neurological disorders including epilepsy, addiction and inflammatory skin conditions. The disclosure further describes the use of fluorinated-CBD derivatives for treating inflammatory skin conditions.
IPC Classes ?
- A61K 31/05 - Phenols
- A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]
- A61K 9/00 - Medicinal preparations characterised by special physical form
- A61K 31/015 - Hydrocarbons carbocyclic
|
2.
|
Pharmaceutical compositions comprising cannabidiol and beta-caryophyllene and methods for their use
| Application Number |
16698070 |
| Grant Number |
11154515 |
| Status |
In Force |
| Filing Date |
2019-11-27 |
| First Publication Date |
2020-03-26 |
| Grant Date |
2021-10-26 |
| Owner |
Phytecs, Inc. (USA)
|
| Inventor |
- Biro, Tamas
- Russo, Ethan B.
|
Abstract
The disclosure describes compositions comprising beta-caryophyllene (BCP) and cannabidiol (CBD). The disclosure also describes compositions which further introduce low levels of THC. The disclosure further describes methods of making and using said compositions, including for the treatment of chronic pain, neurological disorders including epilepsy, addiction and inflammatory skin conditions. The disclosure further describes the use of fluorinated-CBD derivatives for treating inflammatory skin conditions.
IPC Classes ?
- A61K 31/05 - Phenols
- A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]
- A61K 9/00 - Medicinal preparations characterised by special physical form
- A61K 31/015 - Hydrocarbons carbocyclic
|
3.
|
PHARMACEUTICAL COMPOSITIONS COMPRISING CANNABIDIOL AND BETA-CARYOPHYLLENE AND METHODS FOR THEIR USE
| Application Number |
US2018035474 |
| Publication Number |
2018/222923 |
| Status |
In Force |
| Filing Date |
2018-05-31 |
| Publication Date |
2018-12-06 |
| Owner |
PHYTECS, INC. (USA)
|
| Inventor |
- Biro, Tamas
- Russo, Ethan B.
|
Abstract
The disclosure describes compositions comprising beta-caryophyllene (BCP) and cannabidiol (CBD). The disclosure also describes compositions which further introduce low levels of THC. The disclosure further describes methods of making and using said compositions, including for the treatment of chronic pain, neurological disorders including epilepsy, addiction and inflammatory skin conditions. The disclosure further describes the use of fluorinated-CBD derivatives for treating inflammatory skin conditions.
IPC Classes ?
- A61K 36/185 - Magnoliopsida (dicotyledons)
- A61K 31/05 - Phenols
- A61K 31/35 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- C07C 39/373 - Halogenated derivatives with all hydroxy groups on non-condensed rings and with unsaturation outside the aromatic rings
- C07C 39/42 - Halogenated derivatives containing six-membered aromatic rings and other rings
|
|
